Summit Global Investments’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,888
Closed -$230K 616
2023
Q4
$230K Sell
1,888
-481
-20% -$53.7K 0.02% 477
2023
Q3
$266K Sell
2,369
-250
-10% -$31.7K 0.02% 444
2023
Q2
$381K Buy
2,619
+2
+0.1% +$272 0.03% 385
2023
Q1
$338K Buy
2,617
+303
+13% +$38K 0.03% 404
2022
Q4
$295K Buy
2,314
+3
+0.1% +$348 0.02% 394
2022
Q3
$242K Sell
2,311
-48
-2% -$5.27K 0.02% 423
2022
Q2
$248K Sell
2,359
-75
-3% -$8.9K 0.02% 424
2022
Q1
$311K Buy
+2,434
New +$293K 0.02% 407

Other funds holding ZBH

Summit Global Investments's ZBH Position: Q1 2024 in Review

Summit Global Investments sold out of Zimmer Biomet (ZBH) in Q1 2024, closing a stake of 1,888 shares — an estimated $230K sold.

Summit Global Investments first reported a position in ZBH in Q1 2022 and held it in 8 quarters. The position peaked at $381K in Q2 2023. 1,011 funds tracked by Wall St. Rank hold ZBH as of Q1 2024.

  • Summit Global Investments reported no remaining Zimmer Biomet position as of Q1 2024 after selling out during the quarter.
  • Summit Global Investments sold 1,888 Zimmer Biomet shares in Q1 2024, an estimated $230K.
  • Summit Global Investments first reported a position in Zimmer Biomet in Q1 2022 and held it in 8 quarters.
  • Summit Global Investments's Zimmer Biomet position peaked at $381K in Q2 2023.
  • 1,011 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2024.

Based on Summit Global Investments's 13F filing for Q1 2024, filed 29 Apr 2024.